A Study to Explore the Role of Gut Flora in ALS
NCT04150809 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding ALS
Conditions
- ALS
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
Interventions
- OTHER
-
No intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Intestinal Microbiome Transplant in ALS
NCT07017946 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis
NCT05889572 ·Status: COMPLETED ·Phase: PHASE1
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Natural History Study of MNGIE
NCT04245917 ·Status: SUSPENDED
-
Amyotrophic Lateral Sclerosis Registry
NCT05892822 ·Status: UNKNOWN
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Predictive Factors of Progression of Motor Neurone Disease
NCT02360891 ·Status: COMPLETED
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Exposure to Neurotoxins as Risk Factors for ALS
NCT00340301 ·Status: COMPLETED
-
Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897 ·Status: COMPLETED
-
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235 ·Status: RECRUITING
-
Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)
NCT00838617 ·Status: COMPLETED
-
Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS
NCT03090932 ·Status: TERMINATED
-
A Longitudinal Analysis of Biomarkers in Patients With ALS
NCT05309408 ·Status: UNKNOWN
-
Multicenter ALS Imaging Study
NCT06735014 ·Status: RECRUITING
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
NCT02559869 ·Status: COMPLETED
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING
-
Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis
NCT02893605 ·Status: COMPLETED
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
NCT01459302 ·Status: WITHDRAWN
-
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 ·Status: COMPLETED